Back to Screener

Healthcare

CRISPR Therapeutics AG(CRSP)

Live Price

Offline

$54.00

+0.84% today

1Y Change

+14.67%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$5.05B
Revenue Growth
-90.0%
EPS Growth
-49.1%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

CRISPR Therapeutics AG (CRSP) is a Healthcare stock with a market cap of $5.05B. The stock last traded around $54.00 and up 14.7% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -90.0%, EPS growth of -49.1%, a dividend yield of 0.0%. What stands out right now is revenue -90.0%, EPS -49.1%, free cash flow -139.1% with operating margin -13408.3% and ROIC -21.1%. Valuation already assumes a fairly strong business story at price/sales 1231.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CRSP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CRSP vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CRSP

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CRSP Max Drawdown

-42.25%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CRSP and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est -1.23
โ€”
โ€”
Est 5503.4B
โ€”
May 5
โ€”
Feb 12, 26
โœ—
-1.37
Est -1.15
-19.1%
864.0B
Est 4718.9B
-81.7%
Feb 12
โ€”
Nov 10, 25
โœ“
-1.17
Est -1.26
+7.1%
889.0B
Est 9121.7B
-90.3%
Nov 10
โ€”
Aug 4, 25
โœ“
-1.29
Est -1.47
+12.2%
892.0B
Est 9436.8B
-90.5%
Aug 4
โ€”
May 6, 25
โœ—
-1.58
Est -1.27
-24.4%
865.0B
Est 5964.7B
-85.5%
May 6
โ€”
Feb 11, 25
โœ“
-0.44
Est -1.15
+61.7%
35000.0B
Est 8055.1B
+334.5%
Feb 11
โ€”
Nov 5, 24
โœ“
-1.01
Est -1.33
+24.1%
602.0B
Est 7698.5B
-92.2%
Nov 5
โ€”
Aug 5, 24
โœ—
-1.49
Est -1.37
-8.8%
517.0B
Est 16570.0B
-96.9%
Aug 5
โ€”
May 8, 24
โœ“
-1.43
Est -1.63
+12.3%
504.0B
Est 3540.0B
-85.8%
May 8
โ€”
Feb 21, 24
โœ“
1.10
Est -0.07
+1671.4%
200000.0B
Est 28110.0B
+611.5%
Feb 21
โ€”
Nov 6, 23
โœ“
-1.41
Est -1.98
+28.8%
โ€”
Est 7960.0B
โ€”
Nov 6
โ€”
Aug 7, 23
โœ“
-0.98
Est -2.18
+55.0%
70000.0B
Est 1710.0B
+3993.6%
Aug 7
โ€”
May 8, 23
โœ“
-0.67
Est -1.67
+59.9%
100000.0B
Est 1710.0B
+5747.9%
May 8
โ€”
Feb 21, 23
โœ“
-1.41
Est -2.32
+39.2%
6.0B
Est 23.0B
-73.9%
Feb 21
โ€”
Nov 1, 22
โœ“
-2.24
Est -2.30
+2.6%
94.0B
Est 1847.4B
-94.9%
Nov 1
โ€”
Aug 8, 22
โœ—
-2.40
Est -2.23
-7.6%
158.0B
Est 2212.5B
-92.9%
Aug 8
โ€”
May 9, 22
โœ—
-2.32
Est -1.91
-21.5%
178.0B
Est 2800.4B
-93.6%
May 9
โ€”
Feb 15, 22
โœ—
-1.84
Est -1.74
-5.8%
12348.0B
Est 2185.3B
+465.1%
Feb 15
โ€”
Nov 3, 21
โœ“
-1.67
Est -1.69
+1.2%
329.0B
Est 833.8B
-60.5%
Nov 3
โ€”
Jul 29, 21
โœ“
9.44
Est 3.52
+168.2%
900202.0B
Est 845938.8B
+6.4%
Jul 29
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.